Dextran deposits in tissues of patients undergoing haemodialysis.
Recently the possible storage of dextran-related material in patients undergoing regular haemodialysis has been suggested. We examined biopsy and autopsy specimens of 32 patients treated with regular haemodialysis for 61 +/- 34 months. All patients received dextran-40 as a plasma expander because of hypotension during haemodialysis. The same study was carried out in a control group of 11 haemodialysed patients who were given other plasma expanders. In the 11 patients who received larger doses of dextran-40 (0.38 g/kg body weight per week) we found particles in the cytoplasm of macrophages in various organs, which proved PAS positive and diastase resistant on light microscopy, and birefringent on polarisation. Electron microscopy revealed a fibrillar structure, but ionic analysis by electronic sampler on scanning electron microscopy excluded the presence of silicon. No intracellular inclusions were observed in the control group, nor in the patients given dextran-40 in doses lower than 0.08 g/kg body weight per week. As we also found a linear relationship between the number of particles and the dextran-40 doses given, we hypothesise that the material demonstrated in the macrophages is a structurally modified dextran.
Bergonzi
G
G
Renal Unit, Piacenza Hospital, Italy.
Paties
C
C
Vassallo
G
G
Zangrandi
A
A
Poisetti
P G
PG
Ballocchi
S
S
Fontana
F
F
Scarpioni
L
L
D003593:Cytoplasm / Q000648:ultrastructure; D003911:Dextrans / Q000378:metabolism*; D006801:Humans; D007668:Kidney / Q000378:metabolism / Q000473:pathology; D007676:Kidney Failure, Chronic / Q000378:metabolism / Q000473:pathology* / Q000628:therapy; D008854:Microscopy, Electron; D008855:Microscopy, Electron, Scanning; D006435:Renal Dialysis / Q000009:adverse effects*
D003911:Dextrans